Domains | Number of items |
---|---|
l. Patient education information | |
Background on the disease | 4 |
Symptoms | 5 |
Diagnosis | 5 |
Allergen identification and avoidance | 19 |
Information on corticosteroid nasal sprays | 15 |
How to use them | 19 |
The tips of effective administration | 5 |
Nasal spray cleaning | 6 |
Antihistamines | 10 |
Decongestants | 19 |
Nasal saline | 13 |
What to do when symptoms get worse | 6 |
What happens when AR is not well controlled | 4 |
II. Pharmacist counselling scopes and algorithm | |
Patient selection criteria | 1 |
Symptom control assessment and monitoring | 1 |
Quality of life assessment | 1 |
Setting the goal of treatment | 1 |
Demonstrating the technique of intranasal corticosteroid administration | 2 |
Assessing the technique of using nasal spray device | 2 |
Providing guidance in assessing concerns of using nasal spray | 5 |
Teaching the patient an alert sign | 3 |
Conducting follow-up pharmaceutical care when necessary | 1 |
Patient discharge criteria | 1 |
Pharmaceutical care algorithm in the management of AR | 1 |
Listed guidance in addressing patients’ concerns about treatments | 6 |
Discussed with patients about medication adherence | 4 |
Adapted ARIA guideline stepwise treatment approach | 1 |
Pharmacotherapy agents of AR treatments | 13 |